- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Radiotherapy Market Forecast to Reach $9.62 Billion by 2030
Driven by technological advancements and rising cancer research investment
Published on Mar. 9, 2026
Got story updates? Submit your updates here. ›
The global radiotherapy market is projected to reach USD 9.62 billion by 2030, growing at a CAGR of 4.9% from 2024 to 2030, according to a new report by MarketsandMarkets. The market is driven by technological advancements in radiotherapy technologies and the rising R&D investment for cancer research, as well as increased focus on invasive methods for cancer care.
Why it matters
Radiotherapy is a critical component of cancer treatment, and advancements in this field can significantly improve patient outcomes. The growth of the radiotherapy market indicates increased adoption of these technologies globally, which could lead to better access to effective cancer treatments.
The details
The radiotherapy market is segmented by technology, procedure, cancer type, and end-user. The external beam radiotherapy (EBRT) segment, which includes MR LINAC, stereotactic, and particle therapy, is expected to see the highest growth. In terms of procedures, image-guided radiotherapy (IGRT), intensity-modulated radiotherapy (IMRT), and 3D conformal radiotherapy (3D-CRT) are the key growth areas. The market is also segmented by cancer type, with prostate, breast, lung, and colorectal cancer being the major focus areas. Hospitals are expected to dominate the end-user segment during the forecast period.
- The radiotherapy market is projected to reach USD 9.62 billion by 2030.
- The forecast period for this market is from 2024 to 2030.
The players
Siemens Healthineers AG
A German medical technology company that is a major player in the radiotherapy market.
Varian Medical Systems, Inc.
An American company that is a leading provider of radiotherapy equipment and software.
Elekta
A Swedish company that is a major manufacturer of radiotherapy equipment and software.
Accuray Incorporated
An American company that specializes in the development of advanced radiotherapy technologies.
IBA
A Belgian company that is a leading provider of particle therapy solutions for cancer treatment.
What’s next
As the radiotherapy market continues to evolve, it will be important to monitor the adoption of new technologies, the development of innovative treatment approaches, and the impact on patient outcomes. Ongoing research and investment in this field will be crucial to driving further advancements.
The takeaway
The growth of the radiotherapy market reflects the increasing importance of this technology in the fight against cancer. As new and more effective radiotherapy solutions become available, patients may have greater access to life-saving cancer treatments, potentially improving outcomes and quality of life.
